News Search Results
Feb 13, 2025, 09:30 ET Envisagenics Expands Executive Leadership with the Appointment of Sudhir Rao as Chief Business Officer
YORK, Feb. 13, 2025 /PRNewswire/ -- Envisagenics, an AI-driven biotechnology company revolutionizing RNA splicing research and therapeutics, has appointed Sudhir Rao, M.S., MBA as Chief Business
More news about: Envisagenics, Inc.
Feb 13, 2025, 09:30 ET T-CURX GmbH Enters into Technology Access Agreement with Kytopen
across a range of cell types, payloads, and therapeutic applications. Kytopen has recently disclosed strategic partnerships with industry-leading biotechnology companies, contract development and manufacturing organizations (CDMOs), and cell therapy-focused medical centers. Kytopen continues to engage strategic
More news about: Kytopen
Feb 13, 2025, 09:00 ET Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
of Newronika. About the Investors ENEA Tech e Biomedical is an Italian foundation supporting high-impact projects in biotechnology, medical devices, and life sciences, focusing on transformative solutions for global healthcare challenges. (
More news about: Newronika
Feb 13, 2025, 09:00 ET Roche Elecsys sFlt-1/PlGF ratio for preeclampsia receives FDA 510(k) clearance, offering a fast and reliable way to predict the risk of developing severe preeclampsia
Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Feb 13, 2025, 08:30 ET NAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORS
Johns Hopkins University School of Medicine. Dr. Ostrove has served on multiple boards and is also a past Board member of the Biotechnology Innovation Organization (BIO). Chris Mason, MD, Ph.D. has over 30 years of cell and gene therapy experience
More news about: Navega Therapeutics
Feb 13, 2025, 08:30 ET TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial
Feb. 13, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has concluded dosing
More news about: TC BioPharm
Feb 13, 2025, 07:30 ET Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Feb 13, 2025, 07:00 ET European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)
MARBURG, Germany, Feb. 13, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced that the European Commission (EC) has approved ANDEMBRY® (garadacimab), the first and
More news about: CSL Behring
Feb 13, 2025, 07:00 ET Mair Therapeutics Secures Pre-Seed Funding and Launches to Pioneer Therapies for Parkinson's Disease
pre-seed funding and launch of Mair Therapeutics. Headquartered in Nijmegen, The Netherlands, Mair Therapeutics is a biotechnology startup focused on developing transformative treatments for neurodegenerative disorders. Mair Therapeutics brings together a team of entrepreneurs,
More news about: Mair Therapeutics
Feb 13, 2025, 06:05 ET IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
transactions, corporate strategy and other investment banking services representing more than $65 billion of value for biotechnology companies worldwide.Appointed Stu Dorman as Chief Commercial Officer. Mr. Dorman brings over 20 years of global commercialization experience
More news about: IDEAYA Biosciences, Inc.
Feb 13, 2025, 05:53 ET Accropeutics Announces First Patient Dosed in Phase Ib Study of RIPK2 Inhibitor AC-101
Feb. 13, 2025 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated diseases,
More news about: Accropeutics Inc.
Feb 13, 2025, 05:45 ET ICON Public Limited Company Class Action: The Gross Law Firm Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Feb 13, 2025, 03:00 ET Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
of Newronika. About the Investors ENEA Tech e Biomedical is an Italian foundation supporting high-impact projects in biotechnology, medical devices, and life sciences, focusing on transformative solutions for global healthcare challenges. (
More news about: Newronika
Feb 13, 2025, 02:00 ET Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa
TOKYO, Feb. 13, 2025 /PRNewswire/ -- Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has
More news about: Restore Vision Inc.
Feb 12, 2025, 21:30 ET Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies
Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes
More news about: Frost & Sullivan
Feb 12, 2025, 21:30 ET Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies
Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes
More news about: Frost & Sullivan
Feb 12, 2025, 20:04 ET DDB Capital Strengthens Alabama Portfolio with Bold Acquisition
hub for innovation and economic growth, the Huntsville area continues to attract major investments in aerospace, biotechnology, and advanced manufacturing. Situated only 12 miles from Huntsville International Airport, this site offers unparalleled
More news about: DDB Capital
Feb 12, 2025, 19:00 ET MimiVax Announces Positive Interim Analysis in Ongoing SurVaxM Clinical Trial
MimiVax, Inc. is a Delaware-incorporated, clinical-stage biotechnology company focused on immunotherapy research and clinical translation of new agents for cancer treatment. MimiVax was formed as a spin-off
More news about: MimiVax, Inc.
Feb 12, 2025, 15:56 ET ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Feb 12, 2025, 15:00 ET Representative Sam Garrison Joined Tampa General Hospital and USF Health Morsani College Of Medicine to Highlight Innovation in Health Care at Florida's State Capitol
as a foremost destination for world-class clinical care, exceptional academics, cutting-edge medical research, and innovative life sciences and biotechnology companies. By serving as a catalyst for job creation, a more prosperous community and a healthier population, the TMRD is elevating Florida's
More news about: Tampa General Hospital
Feb 12, 2025, 11:00 ET Extended Reality Market Size Worth $139.07 Billion, Globally, by 2031 Growing at 28.4% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 12, 2025, 10:45 ET A2P SMS Market Size Worth $91.59 Billion, Globally, by 2031 Growing at 3.4% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 12, 2025, 10:30 ET Cell Counting Market to Hit USD 16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™
rapidly due to their superior accuracy, efficiency, and integration of artificial intelligence. Furthermore, the expanding biopharmaceutical and biotechnology sectors significantly contribute to this growth, as cell counting is increasingly used in drug discovery, cell therapy, and vaccine development.
More news about: MarketsandMarkets
Feb 12, 2025, 10:30 ET Digital Identity Solutions Market Size Worth $159.93 Billion, Globally, by 2031 Growing at 21.2% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 12, 2025, 08:30 ET Emmes Group advances data security as ISMS certified ISO compliant
Emmes CRO has supported more than 2,000 clinical trials across numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. The company has built industry leading capabilities in cell and gene therapy,
More news about: Emmes Group